SteadyMed Ltd.
Healthcare · Pharmaceutical Preparations · L3 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY17 | FY16 | FY15 | FY14 | |
|---|---|---|---|---|
| Revenue | $1.1M | $1.1M | $869,000 | — |
| Operating income | −$20.4M | −$27.4M | −$24.7M | −$15.8M |
| Net income | −$23.2M | −$25.9M | −$25.0M | −$19.0M |
| Total assets | $38.5M | $28.2M | $35.2M | $10.3M |
| Total liabilities | — | — | — | — |
| Equity | $23.8M | $14.3M | $28.5M | −$36.3M |
| EPS (diluted) | — | — | — | — |
| Shares out. | 20.1M | 13.6M | 13.6M | 502,224 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2017- Operating margin
- −1918.8%
- Net margin
- −2178.9%
- Return on equity
- −97.5%
- Return on assets
- −60.3%
- Return on capital (ROCE)
- −57.2%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $1.18
- Revenue growth (YoY)
- 0.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2017- Accruals / assets
- −2.5%clean
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 4 warning● 1 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Other material eventAug 30, 2018
- Results of operationsAug 14, 2018
- Shareholder voteAug 1, 2018
- Other material eventJul 20, 2018
- Other material eventJun 29, 2018
- Results of operationsMay 15, 2018
- Entered a material agreement · Other material eventApr 30, 2018
- Results of operationsMar 30, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 15-12BSep 10, 2018
- 4Sep 7, 2018
- SC 13D/AAMENDMENT NO. 4Sep 7, 2018
- EFFECTSep 6, 2018
- EFFECTSep 6, 2018
- EFFECTSep 6, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
- 4FORM 4 SUBMISSIONSep 4, 2018
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.